SCHEMBL1629022

SCHEMBL1629022

COc1cc(O)c(-c2ccnn2-c2ccccc2C)cc1S(=O)(=O)Nc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALPL P05186 9/20 0.45
BRD4 O60885 1/20 0.43
BRD2 P25440 1/20 0.43
BRD3 Q15059 1/20 0.43
HSP90AA1 P07900 2/20 0.42
MAPT P10636 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HSD17B2 P37059 1/20 0.41
GLA P06280 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
RECQL P46063 1/20 0.40
GAA P10253 1/20 0.40
MEN1 O00255 1/20 0.40
KDM1A O60341 1/20 0.40
KMT2A Q03164 1/20 0.40
NR3C2 P08235 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1628681 0.92 ALPL (0.47) ALPLBRD4BRD2BRD3MAPT
SCHEMBL1629197 0.90 ALPL (0.45) ALPLBRD4BRD2BRD3HSP90AA1
SCHEMBL1628838 0.89 HSP90AA1 (0.47) BRD4BRD2BRD3HSP90AA1MAPT
SCHEMBL1628685 0.86 HSP90AA1 (0.46) HSP90AA1ALDH1A1GLAGAANR3C2
SCHEMBL1629087 0.86 CYP1A2 (0.52) BRD4BRD2BRD3HSP90AA1ALDH1A1
SCHEMBL1629242 0.86 HSP90AA1 (0.46) BRD4HSP90AA1ALDH1A1CYP3A4MEN1
SCHEMBL1630439 0.82 ALPL (0.47) ALPLBRD4BRD2BRD3MAPT
SCHEMBL1630515 0.81 HSP90AA1 (0.48) HSP90AA1ALDH1A1CYP3A4CYP2C9TSHR
SCHEMBL1629805 0.79 NR3C2 (0.41) BRD4HSP90AA1ALDH1A1CYP3A4MEN1
SCHEMBL1628808 0.78 ALDH1A1 (0.42) ALPLHSP90AA1ALDH1A1GLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP claimed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P ALPL 4725/4885BRD4 1016/4885BRD2 2355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.